Valuation: Proteome Sciences plc

Market Cap 4.98M 6.58M 5.88M 5.48M 9.37M 637M 9.46M 65.82M 25.75M 324M 24.71M 24.17M 1.04B P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 19.97M 26.39M 23.56M 21.98M 37.58M 2.56B 37.94M 264M 103M 1.3B 99.08M 96.93M 4.18B EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.48%
Yield 2024 *
-
Yield 2025 -
1 day-4.58%
1 week-6.55%
Current month-6.87%
1 month-3.21%
3 months-31.22%
6 months-14.24%
Current year-45.80%
1 week 1.2
Extreme 1.2
1.7
1 month 1.11
Extreme 1.11
1.7
Current year 1.11
Extreme 1.11
4.4
1 year 1.11
Extreme 1.11
4.4
3 years 1.11
Extreme 1.11
7.5
5 years 1.11
Extreme 1.11
8.79
10 years 1.11
Extreme 1.11
11.25
Manager TitleAgeSince
Corporate Officer/Principal - 31/03/2017
Corporate Secretary - 31/07/2017
Director TitleAgeSince
Chairman 73 29/06/2014
Director/Board Member 62 31/12/2009
Director/Board Member 71 30/06/2014
Date Insider Type Main position Quantity % Market Cap. Importance
14/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
14/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
06/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
-4.58%-6.55%-26.56%-80.36% 6.58M
-0.52%+1.73%-26.74%+1.66% 171B
+2.37%+1.44%-10.41%+16.71% 109B
-0.36%+0.56%-26.86%+2.88% 106B
-2.49%-1.11%-48.69%-12.43% 75.43B
+1.32%+3.76%+3.48%+72.63% 60.54B
-0.44%+6.13%+10.95%+67.50% 53.16B
+0.64%+1.96%-6.38%-31.69% 49.07B
+0.85%-1.01%-18.64%+15.89% 39.92B
-0.24%-2.52%+24.01%+1.16% 31.81B
Average -0.36%+0.49%-12.58%+5.40% 69.58B
Weighted average by Cap. +0.05%+0.68%-16.84%+12.33%

Financials

2024 2025
Net sales 4.89M 6.46M 5.77M 5.38M 9.2M 625M 9.29M 64.59M 25.26M 318M 24.25M 23.72M 1.02B 3.76M 4.96M 4.43M 4.13M 7.07M 481M 7.14M 49.64M 19.42M 244M 18.64M 18.23M 786M
Net income -3.41M -4.5M -4.02M -3.75M -6.41M -436M -6.47M -45.02M -17.61M -222M -16.9M -16.53M -712M -3.06M -4.04M -3.61M -3.37M -5.76M -392M -5.82M -40.46M -15.82M -199M -15.19M -14.86M -640M
Net Debt 13.39M 17.7M 15.81M 14.74M 25.2M 1.71B 25.45M 177M 69.24M 871M 66.45M 65.01M 2.8B 14.99M 19.81M 17.69M 16.5M 28.21M 1.92B 28.48M 198M 77.49M 975M 74.37M 72.75M 3.13B
Projected Income Statement - Annual - Proteome Sciences plc
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
08/10/26 GBX 1.355 -4.58% 0
07/10/26 GBX 1.420 -2.41% 10,410
06/10/26 GBX 1.455 +3.93% 4,527
05/10/26 GBX 1.400 -3.45% 9,103
02/10/26 GBX 1.450 0.00% 4,730